StockData
Vivos Therapeutics, Inc. logo

Vivos Therapeutics, Inc. (VVOS) stock

VVOSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.08−0.00 (-3.04%)

Close on Nov 17, 2026Market cap $1.60MP/E –Yield –

Vivos Therapeutics cash

Cash and short-term investments held at the end of each period.

Vivos Therapeutics's cash was $1.77M at Jun 30, 2026. For fiscal 2025 it was $2.03M, down 67.6% from the year before. The highest annual figure on record is $24.03M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.03M-67.6%
FY2024Dec 31, 2024$6.26M+281.0%
FY2023Dec 31, 2023$1.64M-53.3%
FY2022Dec 31, 2022$3.52M-85.4%
FY2021Dec 31, 2021$24.03M+32.0%
FY2020Dec 31, 2020$18.21M+3779.0%
FY2019Dec 31, 2019$469.35K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.77M-59.7%
Q1 FY2026Mar 31, 2026$2.11M-9.9%
Q4 FY2025Dec 31, 2025$2.03M-67.6%
Q3 FY2025Sep 30, 2025$3.09M-51.1%
Q2 FY2025Jun 30, 2025$4.40M-36.2%
Q1 FY2025Mar 31, 2025$2.34M-10.3%
Q4 FY2024Dec 31, 2024$6.26M+281.0%
Q3 FY2024Sep 30, 2024$6.31M+538.8%
Q2 FY2024Jun 30, 2024$6.90M+75.1%
Q1 FY2024Mar 31, 2024$2.61M-62.9%
Q4 FY2023Dec 31, 2023$1.64M-53.3%
Q3 FY2023Sep 30, 2023$988.00K-85.3%
Q2 FY2023Jun 30, 2023$3.94M-68.9%
Q1 FY2023Mar 31, 2023$7.05M-60.5%
Q4 FY2022Dec 31, 2022$3.52M-85.4%
Q3 FY2022Sep 30, 2022$6.72M-76.5%
Q2 FY2022Jun 30, 2022$12.66M-63.0%
Q1 FY2022Mar 31, 2022$17.83M+26.8%
Q4 FY2021Dec 31, 2021$24.03M+32.0%
Q3 FY2021Sep 30, 2021$28.53M+5979.5%
Q2 FY2021Jun 30, 2021$34.20M–
Q1 FY2021Mar 31, 2021$14.06M–
Q4 FY2020Dec 31, 2020$18.21M–
Q4 FY2019Dec 31, 2019$469.35K–

More Vivos Therapeutics figures

See a number that looks wrong?